Harjivan Kohli, MD
Urology · Fullerton, CANPI 1205322393
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.1%), education and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Intuitive Surgical at 59.4% of the total. 2025 is the largest year on record at $1,689, 3.7 times the $452 reported in 2023. That places this record below the midpoint for urology clinicians in CA, where the typical reported total is $2,485.
Across 25 payments — averaging $87.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Procept Biorobotics Corporation$444
- Medtronic$276
- Teleflex LLC$31
- Immunitybio, Inc.$28
- Convatec Inc.$25
- plus $79 from 4 others
What the payments were for
- Travel & lodging$40419%
- Food & beverage$1,02547%
- Education$75034%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $1,296 |
| Procept Biorobotics Corporation | 8 | $444 |
| Medtronic | 3 | $276 |
| Teleflex LLC | 1 | $31 |
| Immunitybio, Inc. | 1 | $28 |
| Convatec Inc. | 1 | $25 |
| Agiliti Surgical, Inc. | 1 | $22 |
| KARL Storz Endoscopy-america | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Olympus America Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,179 in reported general payments places this provider in the 45th percentile of 1,324 urology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 124 | $123,708 |
| GemtesaVibegron | 30 | $34,529 |
| Tamsulosin Hcl | 643 | $10,631 |
| Trospium Chloride ErTrospium Chloride | 23 | $6,693 |
| Estradiol | 47 | $3,412 |
| Methenamine Hippurate | 25 | $2,961 |
| Silodosin | 32 | $1,892 |
| Finasteride | 94 | $1,862 |
| Testosterone Cypionate | 16 | $1,406 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 32 | $753 |
| Cefpodoxime Proxetil | 17 | $646 |
| Tadalafil | 12 | $302 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $177 |
| Ciprofloxacin Hcl | 20 | $130 |
| Cephalexin | 52 | $90 |
Paid to pharmacies, not to this prescriber.
Other urology in Fullerton
- Stephen FreedlandWest Hollywood$1.9M
- Arie BelldegrunLos Angeles$1.8M
- Mihir DesaiLos Angeles$1.5M
- Steven WilsonIndio$1.1M
- Stuart HoldenLos Angeles$1.1M
- Elward CrawfordSan Diego$849K
- Edward UchioOrange$849K
- Victor ChingUpland$809K
- Jaime LandmanOrange$657K
- William AronsonLos Angeles$540K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.